TCM Treatment of Rheumatoid Arthritis by Supplementing the Kidney and Invigorating the Blood Circulation

The therapeutic effects in treating the intermediate and late rheumatoid arthritis by supplementing the kidney and invigorating blood circulation were observed. In the 43 cases of the treatment group, No. 2 Qu Feng Shi Ling capsules (祛风湿灵胶囊2号) and Fenbid (芬必得) were prescribed, while in the 39 cases of the control group Lei Gong Teng Tablets (雷公藤总甙片) and Fenbid were given. The results showed that the total effective rate in the treatment group was more satisfactory than that in the control (P<0.05 or P<0.01). With less toxic effects, the former could better improve the local swelling and lower the blood viscosity.

Overview of effect of traditional Chinese medicine on diabetic kidney disease by regulating podocyte

Diabetic kidney disease has now become the leading cause of end-stage renal disease.Podocytes are an important filtration barrier of the glomerulus,and their damage plays an important role in the occurrence and progression of glomerular sclerosis and DKD.This article discusses the molecular mechanism of traditional Chinese medicine on the protection of podocyte damage in diabetic kidney disease from the aspects of anti-oxidative stress,activating autophagy,and regulating signal pathways,in order to further deepen the modern material basis theory of traditional Chinese medicine treatment and provide reference for the treatment of DKD.

Regulating and tonifying spleen and kidney traditional Chinese medicine in the treatment of chronic uric acid nephropathy: A systematic review

Objective:To systematically evaluate the efficacy and safety of traditional Chinese medicine for regulating spleen and kidney.Methods:We developed a search strategy and then retrieved the database including CNKI,Wanfang data knowledge service platform,VIP journals resource integration service platform,PubMed,Embasefor randomized controlled trial of regulating spleen and kidney traditional Chinese medicine compared with conventional western medicine in the treatment of chronic uric acid nephropathy.The search deadline was set to June 30,2020.For the included literature,we applied the cochrane collaboration network risk bias assessment tool to evaluate the methodological quality,and evaluated the level of evidence according to GRADE standards.Quantitative data was analyzed by RevMan5.3 software,and trial sequential analysis method was used to analyze its efficiency.Results:A total of 709 cases in 10 articles were included.Compared with the control group,the related traditional Chinese medicine group improved the effective rate[RR=1.45,95%CI(1.32,1.58)],reduced the level of UA[MD=-36.24,95%CI(-41.03,-31.45)],BUN[SMD=-1.27,95%CI(-1.47,-1.07)]and SCR[MD=-36.33,95%CI(-55.79,-16.87),P=0.0003],the difference between the two groups was statistically significant(P<0.05).There was no evidence that a significant adverse reaction occurred.The results of TSA analysis showed that the Chinese medicine group had definite evidence for improving the efficiency.According to the GRADE evaluation criteria,the efficiency,UA,BUN and SCR outcome indicators were extremely low-quality evidence.Conclusions:Traditional Chinese medicine for regulating spleen and kidney in the treatment of chronic uric acid nephropathy improved efficiency,reduced the level of UA,BUN,SCR.Meanwhile,the therapy was proved to be safe.Nevertheless,the conclusions need further high-quality evidence to support.

Advances in TCM Treatment of Skeletal Fluorosis

By consulting and collating the relevant literatures on the treatment of fluorosis in Traditional Chinese medicine, the research progress of TCM in the treatment of fluorosis was summarized. This paper summarizes the treatment of fluorosis in traditional Chinese medicine from the aspects of the traceability of TCM theory, etiology and pathogenesis, syndrome differentiation and cure, special disease specialty and foreign medicine, so as to guide clinical practice. TCM treatment of fluorosis more use of tonifying kidney and bone, activating blood circulation stasis, cold moisturizing, Tongluo pain relief and other methods, based on dispelling evil and tonifying kidney, combined with a variety of treatment methods, in relieving clinical symptoms and improving the quality of life of patients have an irreplaceable role, has been widely recognized, but most of the research reports are their own work experience summary, Lack of uniform diagnosis and treatment standards, and small sample size, data repeatability is weak, future research needs to further enhance the scientific and objective of the experiment, for TCM treatment of fluorosis to provide a scientific and reasonable diagnosis and treatment program, give full play to the advantages of TCM therapy.

Analysis of Traditional Chinese Medicine Syndromes and Treatment Laws of Diabetic Kidney Disease and the Action Mechanism of High-Frequency Chinese Herbs in the Treatment of Diabetic Kidney Disease Based on Real-World Study

Objective Our objective was to analyze the traditional Chinese medicine(TCM)syndrome and treatment laws of diabetic kidney disease(DKD)and the action mechanism of high-frequency Chinese herbs in the treatment of DKD based on realworldstudy.MethodsThe data of patients with DKD who had been treated in the First Hospital Affiliated to Henan Universityof ChineseMedicine from January1,2014to December 31,2021 were retrospectively analyzed through the hospital information management system.The contents of the cases were statistically analyzed using IBM SPsS Statistics 25 software,and the laws of DKDtreatment were summarized.Network pharmacology and molecular docking were used to analyze the action mechanism of high-frequency Chinese herbs in the treatment of DKD.ResultsThe data of a total of 1,201 patients with DKD were included,involving 72 kinds of TCM syndromes.Nine disease nature elements and six disease location elements were extracted,involving 405 Chinese herbs.The top five high-frequency Chinese herbs were Baizhu(Atractylodis Macrocephalae Rhizoma),Fuling(Poria),Huangqi(Astragali Radix),Chuanxiong(Chuanxiong Rhizoma),and Danshen(Salviae Miltiorrhizae Radix et Rhizoma).Thirty kinds of Chinese herbs with the frequency of≥100 were mainly deficiency-tonifying herbs and blood-activating and stasis-eliminating herbs.The medicinal properties were mainly warm and mild,and the medicinal flavors were sweet and bitter mostly.For the meridian tropism,the main meridian tropism of these herbs is spleen meridian and lung meridian.The clustering method.

Clinical observation of kidney-qi deficiency syndrome patients with hypertension by Bushenjiangya decoction

OBJECTIVE: To observe the clinical efficacy of Bushenjiangya(reinforcing kidney and lowering blood pressure) decoction in curing hypertension of kidney Qi deficiency type. METHODS: First 60 patients with hypertension of kidney Qi deficiency type were divided into control group and treatment group randomly; the conventional western medicine was given to patients of the control group for antihypertensive therapy, while the traditional Chinese medicine Bushenjiangya decoction was added for patients in the treatment group based on the therapy for those in control group; after 2 months, the blood pressure, clinical efficacy and urine microalbumin changes of patients in the two groups before and after the treatment were observed. RESULTS: a. The systolic pressure of patients in the two groups was all reduced obviously(P<0.05); b. The total effective rate of experiment group in antihypertensive effect was 76.7%, while that of control group was 83.3%(P>0.05); c. The total effective rate of experiment group in TCM syndrome effect was 86.7%, while that of control group was 63.3%, showing that the effect of experiment group was better than that of control group(P<0.05); d. The 24 h urine microalbumin reduction of experiment group was better than that of control group(P<0.05). CONCLUSIONS: The curative effect of Bushenjiangya decoction in combination with the western medicine is better than that of simple western medicine for hypertension of kidney Qi deficiency type, and also the urine microalbumin can be obviously reduced to protect the kidney function.

Efficacy and advantages of modified Traditional Chinese Medicine treatments based on"kidney reinforcing"for chronic aplastic ane-mia:a randomized controlled clinical trial

OBJECTIVE:To compare the efficacy of modified treatments based on "kidney reinforcing" in the management of chronic aplastic anemia(CAA),and explore their advantages and specialties.METHODS:One hundred and eleven patients with CAA were randomly divided into three groups:kidney reinforcing alone(KA),"kidney reinforcing and Qi tonifying"(KQ),and "kidney reinforcing and blood circulation invigorating"(KC).Normal and positive control groups were also formed.All patients were treated for 6 months(two courses).Hemograms,Traditional Chinese Medicine(TCM) syndrome scores,and therapeutic effects were assessed,and changes in T-lymphocyte subsets,regulatory T cells and cytokines were detected.RESULTS:The KQ and KC groups had lower TCM syndrome scores than the positive control group after 6 months(P < 0.05).The KQ group had a higher overall efficacy than the positive control group after 3 months(P < 0.05),while platelet counts increased in the KC group after 6 months(P < 0.05).CD3+ T-lymphocyte ratios decreased only in the KQ group,while CD3 + CD4 + CD8-Tlymphocytes increased only in the KC group after 6 months(P <0.05).Levels of interferon-γ,tumor necrosis fac-tor-α,interleukin(IL)-2 and IL-6 decreased and levels of IL-4 and IL-10 increased in all treated groups after 6 months.Levels of IL-6 in the KQ and KC groups were lower than those in the positive control group(P < 0.05).CONCLUSION:Treatments based on kidney reinforcing have a rebalancing effect on cytotoxic and T helper cells,and regulate expression of interferon-γ,IL-2,IL-6 and IL-4.KQ may be more effective in treating CAA,and KC may have an advantage in platelet recovery.

Effect of reinforcing kidney-essence, removing phlegm, and promoting mental therapy on treating Alzheimer's disease

OBJECTIVE: To explore the mechanism of reinforcing kidney-essence, removing phlegm, and promoting mental therapy in treating Alzheimer's disease (AD). METHODS: Sixty patients with AD in Wuhan No.1 Hospital of Traditional Chinese Medicine for Geriatrics from May 2009 to April 2011 were randomly divided into two groups, with 30 in each group. Patients in Bushenhuatanyizhi group (BHY group) took BHY instant granules (6 g, twice per day). Patients in the control group took piracetam (0.8 g, 3 times per day). There were twelve weeks in a course. Changes in the mini-mental state examination (MMSE) score and Activity of Daily Living Scale (ADL) score were analyzed before and after treatment. RESULTS: MMSE scores in the two groups in-creased and ADL scores decreased after treatment, compared with those before treatment (both P< 0.05).The total effective rate was 86.67% in the BHY group (10 very effective, 13 effective, 7 non-responsive). The control group was 57.69% (5 very effective, 16 effective, 9 non-responsive) (P<0.05). Superoxide dismutase levels were increased, lipid peroxide and triglyceride levels decreased after treatment in the BHY group as compared with the control group. CONCLUSION: Reinforcing kidney-essence, removing phlegm, and promoting mental therapy can improve cognitive function and daily life of AD patients. The mechanism of the therapy might be related to improving blood fat, scavenging free radicals, and inhibiting lipid peroxides.

热补针法联合药物铺灸法治疗类风湿关节炎临床研究

目的观察热补针法联合药物铺灸法治疗类风湿关节炎(RA)临床疗效。方法采用随机数字表法将90例RA患者随机分为热补针法组、药物铺灸组及热补针法+药物铺灸组,各30例。热补针法组取关元、足三里和累及关节局部腧穴,予热补针法,每日1次;药物铺灸组取大椎至腰俞区及两旁的华佗夹脊穴,涂擦鲜姜汁及何氏自拟风湿痹痛散,并施以长蛇灸,隔日1次;热补针法+药物铺灸组治疗方法同以上2组。3组均连续治疗15 d。观察3组治疗前后中医症状积分、视觉模拟量表评分(VAS)评分及血清红细胞沉降率(ESR)、类风湿因子(RF)、C反应蛋白(CRP)水平,比较3组临床疗效。结果与本组治疗前比较,3组治疗后中医症状积分、VAS评分及血清ESR、RF、CRP水平均明显下降(P<0.05);3组治疗后比较,热补针法+药物铺灸组上述指标较其他2组改善更为明显(P<0.05)。热补针法+药物铺灸组总有效率为93.3%,明显优于热补针法组(83.3%)和药物铺灸组(80.0%),差异有统计学意义(P<0.05)。结论热补针法联合药物铺灸疗法治疗RA临床疗效满意,可明显减轻RA患者疼痛症状,降低生化指标,抑制免疫反应。

青黄散加补肾健脾中药治疗骨髓增生异常综合征的临床观察

目的观察青黄散加补肾健脾中药治疗骨髓增生异常综合征(MDS)的临床疗效。方法55例MDS患者给予青黄散、补肾健睥汤药及雄性激素等治疗。结果55例MDS患者中,完全缓解11例(20.0%),总有效41例(74.5%)。根据FAB分型,RA/RAS型34例,完全缓解9例(26.5%),总有效28例(82.4%);RAEB型21例,完全缓解2例(9.5%),总有效13例(61.9%),两型间疗效比较差异无统计学意义。按国际预后积分系统(IPSS)评定标准,中危Ⅰ组36例,有效25例(其中完全缓解10例),无效11例。中危Ⅱ组7例,完全缓解1例,有效4例,无效2例。高危组6例,完全缓解0例,有效3例,无效3例。3组疗效比较差异无统计学意义。有效者41例,治疗后白细胞、血红蛋白和血小板计数均较治疗前升高(P<0.05);染色体异常组16例,有效11例(68.8%);染色体正常组33例,有效24例(72.7%);染色体异常与否间疗效比较,差异无统计学意义。结论化瘀补肾为主综合治疗MDS具有确切的临床疗效,疗效与FAB分型、IPSS积分及染色体异常与否无明显相关性。

益气健脾清热解毒法治疗溃疡性结肠炎临床研究

目的观察益气健脾清热解毒法对溃疡性结肠炎的临床疗效以及中医临床证候改善情况。方法将99例溃疡性结肠炎患者随机分为中药组(n=51)和西药组(n=48),分别给予益气健脾清热解毒法立方的中药内服和灌肠以及常规西药内服和灌肠治疗,疗程4周,比较2组临床疗效以及中医临床证候改善情况,并对影响临床疗效的因素进行Pearson相关分析。结果中药组有效率为96.1%,优于西药组79.2%(χ2=6.639,P<0.05);治疗后中药组较西药组在腹胀、纳差、乏力的改善上更为明显(P<0.05或P<0.01);相关分析结果显示,临床疗效与病变部位、病情分级、临床分型和中药干预显著性相关(相关系数为0.30～0.37,P<0.05或P<0.01)。结论益气健脾清热解毒法能有效改善溃疡性结肠炎患者的中医证候,提高临床疗效和患者的生活质量。

中药伍用博宁治疗乳腺癌骨转移痛40例疗效分析

目的:观察补肾活血中药配合博宁治疗晚期乳腺癌骨转移疼痛的疗效。方法:将我科近几年收治的65例晚期乳腺癌骨转移疼痛的病人,分为补肾活血中药伍用博宁治疗组（治疗组）,及单纯博宁治疗组（对照组）。结果:（1）治疗组的止痛效果（70％）优于对照组（52％）,P<0.01;止痛效果;（2）两组均可降低血清中AKP、Ca2+浓度;（3）治疗组可显著降低血小板粘附蛋白的表达,CD-62CD+63、CD+62、CD63疗前、疗后比较P<0.01;而对照组无变化P>0.05。结论:（1）补肾活血中药对博宁内增效作用。其主要机制可能与抑制血小板的激活和释放,以及降低血清中AKP、Ca2+浓度有关。

豁痰健脾法治疗梅尼埃病的临床研究

[目的]探讨中医豁痰健脾法治疗痰湿型梅尼埃病的疗效。[方法]选择2009年3月至2012年3月就诊的128例痰湿型梅尼埃病患者;随机分为治疗组66例和对照组62例,治疗组以豁痰健脾法方药1贴/d,共7d;对照组62例以山茛菪碱10mg静脉滴注1/d次共7d;治疗时间观察患者的临床疗效、整体评分、复发率,对痰湿症状的改善情况等。[结果]治疗组的总有效率为95.5%,对照组为83.9%;两者比较差异有统计学意义(P<0.05)。3个月复发率治疗组为4.7%,对照组为19.2%,两者比较差异有统计学意义(P<0.05),治疗组可明显改善痰湿症状(P<0.01)。[结论]豁痰健脾法方药是治疗痰湿型梅尼埃病的安全有效的方法,值得推广应用。

中医情志护理联合正强化干预模式对急诊静脉输液患儿依从性、疼痛程度及穿刺成功率的影响

目的观察中医情志护理联合正强化干预模式对急诊静脉输液患儿依从性、疼痛程度及穿刺成功率的影响并探讨其作用机制。方法将120例患儿按照随机数字表法分为两组,对照组给予中医情志护理,观察组给予中医情志护理联合正强化干预护理,比较两组患儿的依从性、疼痛程度、穿刺成功率及不良反应。结果观察组患儿的依从性及穿刺成功率分别为93.33%与98.33%,明显高于对照组71.67%与85.00%(P<0.05);观察组患儿的静脉穿刺疼痛程度低于对照组(P<0.05);观察组患儿的不良反应发生率15.00%,低于对照38.33%(P<0.05)。结论中医情志护理联合正强化干预模式可提高急诊静脉输液患儿依从性,降低静脉穿刺疼痛程度,提高穿刺成功率,且不良反应发生率较低。

补肾化瘀法延缓衰老机理研究─—六味丹坤方对老年小鼠自由基代谢的影响

选用自由基代谢为指标，对比观察了补肾六味地黄汤、化瘀丹坤方及补肾化瘀六味丹坤方的延缓衰老作用。实验结果表明：（１）六味地黄汤及丹坤方均能明显增加老年小鼠红细胞ＣＡＴ的活性，增加ＮＰＳＨ的含量，减少肝脑ＭＤＡ含量，即明显改善老年小鼠的自由基代谢紊乱；丹坤方尚能明显增强老年小鼠ＳＯＤ及ＧＳＨ－Ｐｘ的活性；（２）补肾化瘀六味丹坤方的作用明显优于单纯补肾的六味地黄汤或单纯化瘀的丹坤方；（３）补肾化瘀是更为有效的延缓衰老手段，并为衰老的“正虚挟瘀”观点提供了实验证据。

补肾健骨方对维持性血液透析患者肾性骨病与血清Klotho蛋白水平的影响

目的探讨补肾健骨方治疗维持性血液透析患者肾性骨病的临床疗效,以及对血钙、血磷、甲状旁腺激素与血清Klotho蛋白、骨硬化蛋白(Sclerostin)水平的影响。方法选取维持性血液透析患者60例,按随机数字表法分为治疗组与对照组各30例。两组均给予充分透析、降低血磷、维持血钙、控制甲状旁腺激素水平等对症治疗,治疗组在此基础上口服补肾健骨方,疗程4周。观察两组患者的治疗前后的临床疗效、骨痛评分,血清钙、磷、甲状旁腺激素水平,以及血清Klotho蛋白与Sclerostin水平。结果治疗组共有25例完成观察,对照组共有28例完成观察。治疗组总有效率72%,优于对照组50%(P<0.05);治疗后两组疼痛评分均低于同组治疗前(P<0.01),治疗组低于对照组(P<0.01);两组治疗后血钙水平均高于同组治疗(P<0.01),组间差异无统计学意义(P>0.05)。两组治疗后血磷水平均低于同组治疗前(P<0.01),治疗组低于对照组(P<0.01)。两组甲状旁腺激素水平均低于同组治疗前(P<0.01),组间比较差异无统计学意义(P>0.05);治疗组治疗后Klotho蛋白水平高于同组治疗前(P<0.01)且高于对照组(P<0.01),对照组Klotho蛋白水平与同组治疗前比较差异无统计学意义(P>0.05)。两组Sclerostin水平均低于同组治疗前(P<0.05,P<0.01),组间比较差异无统计学意义(P>0.05)。结论维持性血液透析肾性骨病患者在一般治疗基础上口服补肾健骨方,有利于缓解骨痛症状与血磷控制,降低血清Klotho蛋白水平。

补肾健脾化瘀法对围绝经期性激素及血脂影响的临床研究

目的观察补肾健脾化瘀法对围绝经期妇女性激素及血脂的影响。方法选择围绝经期患者377例。按随机数码表按就诊先后随机单盲,分中药组及西药组。中药组(n=188)口服补肾壮骨冲剂治疗。西药组(n=189)应用结合型雌激素加安宫黄体酮治疗。主要观察治疗前后血脂[总胆固醇(TC)、三酰甘油(TG)、高密度脂蛋白-胆固醇(HDL-C)、低密度脂蛋白-胆固醇(LDL-C)]、性激素[雌二醇(E2)、卵泡刺激激素(FSH)、促黄体生成素(LH)]等指标及症状体征积分的变化。结果①脱失情况比较:中药组治疗2年后脱失53例;西药组治疗脱失96例,两组比较有明显差别(P<0.01)。②有效率比较,两组比较无明显差别(P>0.05)。③症状总评分比较,两组治疗后症状总评分均有明显减少,中药组(P<0.01),西药组(P<0.05);组间比较中药组优于西药组(P<0.01)。④性激素和血脂比较:与治疗前相比,差异有统计学意义(P<0.05),组间比较差异无统计学意义(P>0.05)。结论补肾健脾化瘀法中药治疗围绝经期妇女,能纠正紊乱的血脂、性激素各项指标,疗效与雌激素替代疗法相当,具有无副作用、服用方便、经济等优点。

补肾活血法对子宫内膜异位症模型大鼠细胞凋亡基因Bcl-2/Bax的影响

[目的]探讨补肾活血法对子宫内膜异位症模型大鼠细胞凋亡基因bcl-2、baxmRNA表达的影响。[方法]将雌性8～12周龄Wister大鼠分为模型组、中药低剂量组、中药高剂量组及西药组。造模成功并分别给药后,采用电镜及RT-PCR法检测药物干预前后模型大鼠异位子宫内膜的病理形态学及凋亡调控基因bcl-2、bax mRNA的阳性表达情况。[结果]补肾活血高剂量组及西药组的异位内膜组织发生凋亡的改变最为明显,并可明显下调bcl-2 mRNA阳性的表达和提升baxmRNA阳性的表达,而中药低剂量组及模型组的改变不明显。[结论]子宫内膜异位症的发生与细胞凋亡能力的下降有关。补肾活血中药能促进内膜细胞发生凋亡,使异位病灶萎缩、消退。

补肾活血法治疗老年性痴呆临床研究

目的:观察补肾活血中药对老年性痴呆患者的临床疗效。方法:40例老年痴呆患者随机分为补肾活血治疗组、安理申治疗组,治疗24周后,应用MMSE、CDR、ADL量表评价患者临床疗效。结果:两组患者有效率均为55%,两组比较无统计学差异。结论:补肾活血中药可以改善老年痴呆患者认知能力,提高患者生活质量。

辨证分型治疗原发性骨质疏松症的临床研究

为探讨中医辨证分型治疗原发性骨质疏松症的临床疗效,应用院内制剂补肾壮骨丹,辨证分型治疗原发性骨质疏松症,通过近期(服药前后)及远期(停药半年后)临床观察和BMD(骨密度)测定及生化指标(血钙素、尿吡啶酚)检测,确切地对其疗效进行评定。近期及远期与治疗前比较,临床症状、BMD、生化指标(BGP、PYD)均明显改善,统计学处理P<0.05,有显著差异。表明中医辨证分型治疗原发性骨质疏松症疗效显著。